Skip to main content

Therapeutic Approach to the Chronic Active Liver Disease: Summary of a Satellite Symposium

  • Conference paper
Viral Hepatitis and Liver Disease

Abstract

Interferon has been shown to be effective and is now widely used in the treatment of chronic viral hepatitis, but it is not universally effective and is sometimes associated with intolerable side effects. Management of patients who fail to respond to interferon or who relapse is problematic. The focus of this symposium was the efficacy of Stronger Neo-Minophagen C (SNMC) and its immunologic mechanism in the treatment of chronic active liver disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Suzuki H, Fujisawa K, Ohta Y, Takino T, Hirayama C, Shimizu N, Aso Y (1977) Therapeutic efficacy of Stronger Neo-Minophagen C on chronic hepatitis. Igaku No Ayumi 102: 562–578

    Google Scholar 

  2. Fujisawa K, Watanabe Y, Kawase H (1987) The efficacy of long-term intermittent administration of glycyrrhizin in HBeAg-positive chronic active hepatitis. New trends in peptic ulcer and chronic hepatitis. Part II, Chronic hepatitis. Excerpta Medica, Stockholm, pp 127–132

    Google Scholar 

  3. Fujisawa K, Kitahara T, Yamauchi M, Nakajima N, Nakahara M, Ohata S, Mizuhara Y, Toda G, Takeuchi N, Hoshi Y (1991) Indication of IFN therapy for patients with chronic hepatitis C. Proceedings of the 17th Inuyama Symposium on Viral Hepatitis. Chiyu-Gai Igakusha, Tokyo, pp 96–102

    Google Scholar 

  4. Okimasu E, Shiraishi N, Watanabe S, Morimoto Y, Utumi K (1982) Inhibitory effect of glycyrrhizin on the phospholipase A2 activity. Igaku No Ayumi 122: 174–177

    CAS  Google Scholar 

  5. Itoh K, Kumagai K (1983) Augmentation of NK activity by several antiinflammatory agents. Proceedings of International Symposium on Natural Killer Activity and Its Regulation. The 5th International Congress of Immunology. Excerpta Medica, International Congress Series No. 641, pp 460–464

    Google Scholar 

  6. Abe N, Ebina T, Ishida N (1982) Interferon induction by glycyrrhizin and glycyrrhizinic acid in mice. Microbiol Immunol 26: 535–539

    PubMed  CAS  Google Scholar 

  7. Tandon BN, Joshi YK, Acharya SK (1988) Subacute hepatic failure. Natl Med J India 1: 124–127

    Google Scholar 

  8. Marl M (1988) Die Therapie der chronischen Leberentzündungen mit SNMC. Inaug Diss Marburg

    Google Scholar 

  9. Wildhirt E (1988) Ein neuer Weg in der Behandlung chronisch entzündlicher Lebererkrankungen: Glycyrrhizinsäure. Arzt u Krankenhaus 12: 383–387

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer-Verlag Tokyo

About this paper

Cite this paper

Fujisawa, K., Tandon, B.N. (1994). Therapeutic Approach to the Chronic Active Liver Disease: Summary of a Satellite Symposium. In: Nishioka, K., Suzuki, H., Mishiro, S., Oda, T. (eds) Viral Hepatitis and Liver Disease. Springer, Tokyo. https://doi.org/10.1007/978-4-431-68255-4_173

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-68255-4_173

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-68257-8

  • Online ISBN: 978-4-431-68255-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics